Uncategorized

We think Meta’s (META) settlement with state attorneys general (AG) is positive for the company and the social media industry. The state AG cases were the largest and most advanced litigation threat facing the company,…

This fall seems likely to be a busy one for medtech and biopharma, with key policy catalysts coming up for a number of companies. These span from both the far-reaching in terms of most favored…

The pending Contract Year (CY) 2028 Technical and Policy Changes proposal for the Medicare Advantage (MA) insurers [HUM, ALHC, UNH, CVS, ELV, CNC, CLOV, MOH] and MA-exposed providers [AGL, ASTH] could be relatively more consequential…

We continue to believe the odds Democrats win control of the House are greater than 80%, while we give Republicans roughly a 60% chance of retaining the Senate. In this note, we are focusing on…

Following HTFL’s strong 2Q26 results, we have received a number of questions on how Medicare hospital outpatient reimbursement might evolve in light of CMS’s proposal to eventually establish a new payment paradigm for software as…

We wanted to update you on California’s AB 1709, which would restrict personalized feeds, autoplay and other addictive features for users under 16 and would negatively affect Meta (META), Alphabet (GOOGL), Snap (SNAP), Pinterest (PINS),…

Through 2028, Obamacare enrollment faces two statutory headwinds after the large, still unfolding 2026 reset: The 2027 narrowing of ACA subsidy eligibility for certain non-citizens. The 2028 installation of pre-enrollment subsidy eligibility verification. For exchange…

With GKOS’s strong 2Q26 results coming on the heels of five separate MAC stakeholder meetings on the draft iDose LCDs issued in late May, we suspect the final policy – likely out in Oct. /…

With Meta’s (META) latest loss in New Mexico’s child-safety case last Thursday, we wanted to provide a comprehensive state-by-state overview of the litigation and regulatory risks facing social media companies, including Meta, Google (GOOGL), Snap…

While a longer-term thematic positive, we are skeptical Friday’s draft notice [Fact Sheet] outlining the RAPID device Medicare coverage pathway will offer meaningful near-term benefits for industry amid agency capacity constraints. Coming nearly four months…